Market revenue in 2023 | USD 215.6 million |
Market revenue in 2030 | USD 357.6 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.46% in 2023. Horizon Databook has segmented the Japan diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Rising geriatric population is one of the major driving factors for the market growth in Japan. According to Europa, more than one in four people are above 65 years of age. As the geriatric population is at a higher risk of various diseases and disabilities, increase in geriatric population may propel the demand for diabetic care products.
In addition, with increasing healthcare spending, the diabetic foot ulcer treatment market is expected to grow substantially in Japan. For instance, as per Macrotrends, in 2018, Japan spent 10.95% of its GDP on healthcare, whereas expenditure on healthcare had also increased. Furthermore, increase in adoption of advanced products in Japan is expected to fuel the diabetic foot ulcer treatment market over the forecast period.
The diabetic foot ulcer treatment market in Japan is moderately competitive, with the presence of major companies offering devices & care products. Several government organizations and academic & research institutes need these devices.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Japan diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account